Intuitive Surgical, Inc. $ISRG Shares Sold by Gamco Investors INC. ET AL

Key Points

• Gamco Investors INC. ET AL has decreased its stake in Intuitive Surgical, Inc. by 9.8%, now owning 10,067 shares valued at approximately $4.99 million.
• Insider selling activity reveals significant transactions, with SVP Mark Brosius selling 216 shares and EVP Myriam Curet selling 4,500 shares, reflecting notable decreases in their ownership.
• Wall Street analysts have shown confidence in Intuitive Surgical, with multiple brokerage firms raising their price targets, resulting in a consensus target price of $595.95.

Gamco Investors INC. ET AL reduced its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 9.8% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 10,067 shares of the medical equipment provider's stock after selling 1,098 shares during the period. Gamco Investors INC. ET AL's holdings in Intuitive Surgical were worth $4,986,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of the stock. Castleark Management LLC raised its stake in shares of Intuitive Surgical by 3.4% in the 4th quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider's stock valued at $47,221,000 after acquiring an additional 2,990 shares during the period. Arlington Trust Co LLC increased its holdings in Intuitive Surgical by 34.5% in the 1st quarter. Arlington Trust Co LLC now owns 745 shares of the medical equipment provider's stock valued at $369,000 after purchasing an additional 191 shares during the last quarter. Aveo Capital Partners LLC raised its position in Intuitive Surgical by 37.4% in the first quarter. Aveo Capital Partners LLC now owns 727 shares of the medical equipment provider's stock valued at $390,000 after purchasing an additional 198 shares during the period. Aaron Wealth Advisors LLC lifted its stake in Intuitive Surgical by 3.2% during the first quarter. Aaron Wealth Advisors LLC now owns 2,509 shares of the medical equipment provider's stock worth $1,243,000 after purchasing an additional 78 shares in the last quarter. Finally, Longbow Finance SA lifted its stake in Intuitive Surgical by 132.0% during the first quarter. Longbow Finance SA now owns 19,699 shares of the medical equipment provider's stock worth $9,756,000 after purchasing an additional 11,209 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Insider Activity at Intuitive Surgical

In related news, SVP Mark Brosius sold 216 shares of the company's stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the transaction, the senior vice president directly owned 907 shares of the company's stock, valued at $510,740.77. This represents a 19.23% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Myriam Curet sold 4,500 shares of the firm's stock in a transaction that occurred on Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the sale, the executive vice president directly owned 353 shares in the company, valued at approximately $173,845.44. The trade was a 92.73% decrease in their position. The disclosure for this sale can be found here. Insiders sold 15,839 shares of company stock valued at $7,896,972 over the last three months. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $471.15 on Thursday. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The stock has a market cap of $168.90 billion, a PE ratio of 65.71, a P/E/G ratio of 4.97 and a beta of 1.59. The stock's fifty day moving average is $501.89 and its two-hundred day moving average is $519.66.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. The company had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.Intuitive Surgical's revenue for the quarter was up 21.4% on a year-over-year basis. During the same period in the previous year, the business earned $1.78 EPS. On average, research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on ISRG. BTIG Research lifted their price objective on Intuitive Surgical from $566.00 to $571.00 and gave the company a "buy" rating in a research note on Wednesday, July 23rd. UBS Group raised their target price on Intuitive Surgical from $547.00 to $585.00 and gave the company a "neutral" rating in a report on Wednesday, July 23rd. Piper Sandler reiterated an "overweight" rating and set a $595.00 price target (up from $575.00) on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Evercore ISI increased their price target on shares of Intuitive Surgical from $470.00 to $550.00 and gave the stock an "in-line" rating in a research report on Tuesday, July 8th. Finally, Royal Bank Of Canada restated an "outperform" rating and issued a $615.00 price objective on shares of Intuitive Surgical in a report on Tuesday, August 19th. Thirteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, Intuitive Surgical has an average rating of "Moderate Buy" and a consensus target price of $595.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.